Document Type

Journal Article

Publication Date

8-7-2014

Journal

Cell Reports

Volume

8

Issue

3

Inclusive Pages

647-655

DOI

10.1016/j.celrep.2014.06.039

Keywords

Cell Development Disorders, Pervasive--genetics; DNA-Binding Proteins--metabolism; Intellectual Disability--genetics; NF-kappa B--metabolism; Neurons--metabolism; Seizures--genetics

Abstract

Autism spectrum disorder (ASD) and intellectual disability (ID) are often comorbid, but the extent to which they share common genetic causes remains controversial. Here, we present two autosomal-recessive "founder" mutations in the CC2D1A gene causing fully penetrant cognitive phenotypes, including mild-to-severe ID, ASD, as well as seizures, suggesting shared developmental mechanisms. CC2D1A regulates multiple intracellular signaling pathways, and we found its strongest effect to be on the transcription factor nuclear factor κB (NF-κB). Cc2d1a gain and loss of function both increase activation of NF-κB, revealing a critical role of Cc2d1a in homeostatic control of intracellular signaling. Cc2d1a knockdown in neurons reduces dendritic complexity and increases NF-κB activity, and the effects of Cc2d1a depletion can be rescued by inhibiting NF-κB activity. Homeostatic regulation of neuronal signaling pathways provides a mechanism whereby common founder mutations could manifest diverse symptoms in different patients.

Comments

Reproduced with permission of Elsevier B.V. Cell Reports.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Peer Reviewed

1

Open Access

1

Share

COinS